Temozolomide in children with recurrent or refractory CNS tumors
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2014
At a glance
- Drugs Temozolomide (Primary)
- Indications CNS cancer
- Focus Therapeutic Use
- 01 Jan 2009 Status changed to completed, based on information from the current controlled trials (ISRCTN) record.
- 09 Feb 2006 New trial record.